Francesco Perrone

22PUBLICATIONS
121CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)EcocriticismEpidemiological modellingMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Oct 16, 2026
PIK3CA Mutations in Advanced or Recurrent Endometrial Cancer: An Exploratory Molecular Profiling From the Phase II MITO END-3 Study.

|Aug 27, 2026
Study protocol on quality of life and erectile function recovery in unfavorable intermediate-risk prostate cancer: REDI-CaP trial.

|Apr 20, 2026
Ethics in the evaluation of the quality of scientific research: An AIOM-TJ roundtable.

|Feb 25, 2026
Patient-reported financial toxicity within Italian public healthcare system: A cross-sectional analysis in patients with cancer.

Anna Amela Valsecchi, Pamela Festa, Maria Laura Malgarini

|Jan 13, 2026
Adjuvant Durvalumab in Completely Resected Early-Stage Non-Small Cell Lung Cancer.

Glenwood D Goss, Gail E Darling, Virginie Westeel

|Dec 19, 2025
CCDC6 Immunostaining in Conjunction with the Rad51 HRD Assay May Expand PARPi Treatment Eligibility in Patients with HGSOC.

Daniela Criscuolo, Francesco Merolla, Benedetta Pellegrino

Pageof 4

Frequent Collaborators

4 joint publications

Massimo Di Maio

3 joint publications

Raimondo Di Liello

3 joint publications

Sandro Pignata

2 joint publications

Giovanni Luca Scaglione